Patents by Inventor Trilochan Mukkur

Trilochan Mukkur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Defective entities and uses therefor
    Publication number: 20050238657
    Abstract: The present invention discloses the structure and sequence of aroQ from Bordetella pertussis, which are useful inter alia for the production of the genetically modified attenuated Bordetella strains of the present invention and for detecting and isolating variant aroQ genes and expression products. The present invention also discloses attenuated Bordetella strains of pathogenic origin, and more particularly genetically modified Bordetella strains, which have been attenuated by disruption or inactivation of the aroQ gene. The genetically modified Bordetella strain of the present invention has a reduced capacity to propagate in a mammalian host, but remains viable in the host for a period of time sufficient to induce a protective immune response against the natural pathogenic Bordetella counterpart.
    Type: Application
    Filed: December 30, 2002
    Publication date: October 27, 2005
    Applicant: University of Southern Queensland
    Inventors: Rene Cornford-Nairn, Grant Daggard, Trilochan Mukkur, Tony Rossetti